➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Mallinckrodt
Express Scripts
Johnson and Johnson
AstraZeneca

Last Updated: May 10, 2021

DrugPatentWatch Database Preview

Tamoxifen citrate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for tamoxifen citrate and what is the scope of freedom to operate?

Tamoxifen citrate is the generic ingredient in three branded drugs marketed by Mayne Pharma Inc, Astrazeneca, Actavis Labs Fl Inc, Aegis Pharms, Apotex, Eugia Pharma, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Pharmachemie, Roxane, Teva, and Zydus Pharms, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for tamoxifen citrate. Twelve suppliers are listed for this compound.

Drug Prices for tamoxifen citrate

See drug prices for tamoxifen citrate

Drug Sales Revenue Trends for tamoxifen citrate

See drug sales revenues for tamoxifen citrate

Recent Clinical Trials for tamoxifen citrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Baylor College of MedicineEarly Phase 1
TYK Medicines, IncPhase 1
British Columbia Cancer AgencyPhase 2

See all tamoxifen citrate clinical trials

Pharmacology for tamoxifen citrate
Paragraph IV (Patent) Challenges for TAMOXIFEN CITRATE
Tradename Dosage Ingredient NDA Submissiondate
NOLVADEX TABLET;ORAL tamoxifen citrate 017970

US Patents and Regulatory Information for tamoxifen citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 213358-001 Aug 14, 2020 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Roxane TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 076027-002 Feb 20, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Teva TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 074504-001 Apr 28, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Zydus Pharms TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 206694-002 Oct 27, 2017 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Teva TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 074504-002 Apr 28, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Pharmachemie TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 074539-001 Mar 31, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Ivax Sub Teva Pharms TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 075740-002 Feb 20, 2003 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for tamoxifen citrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca NOLVADEX tamoxifen citrate TABLET;ORAL 017970-002 Mar 21, 1994   Get Started for $10   Get Started for $10
Mayne Pharma Inc SOLTAMOX tamoxifen citrate SOLUTION;ORAL 021807-001 Oct 29, 2005   Get Started for $10   Get Started for $10
Astrazeneca NOLVADEX tamoxifen citrate TABLET;ORAL 017970-001 Approved Prior to Jan 1, 1982   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
McKesson
Boehringer Ingelheim
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.